Literature DB >> 23312395

Circulating hematopoietic and endothelial progenitor cells in newborn infants: effects of gestational age, postnatal age and clinical stress in the first 3 weeks of life.

Kim Chi T Bui1, Mark Weems, Manoj Biniwale, Aswathi A George, Ewa Zielinska, Colleen G Azen, Manuel Durand, Hisham Abdel-Azim.   

Abstract

INTRODUCTION: Circulating endothelial progenitor cells (EPC) are bone marrow derived progenitors that can be mobilized by erythropoietin or in response to tissue injury, and participate in vascular repair. EPC are understudied in human neonates. Whether EPC frequency in newborn infants may be influenced by gestational age or postnatal stress is unknown.
METHODS: Blood samples were collected on day 1 of life and weekly for 3 weeks from hospitalized neonates for plasma erythropoietin and flow cytometry analysis for CD34+, CD34+CD45-, CD34+VEGFR2+ and CD34+CD45-VEGFR2+ cells (EPC). Associations between CD34+ cell subsets and clinical parameters were studied.
RESULTS: Forty five patients were enrolled. An inverse correlation with gestational age was observed for CD34+ and CD34+ VEGFR2+ cell frequencies in whole blood (WB) on day 1 (p<0.05). In preterm infants, CD34+ cell frequency decreased with increased postnatal age (p=0.0001) and CD34+VEGFR2+ cell frequency was higher at week 3 than on day 1 in WB (p=0.0002). On day one, CD34+ and CD34+CD45- cell frequencies in the mononuclear cell fraction (MNC) were higher in preterm than term infants (p=0.035 and p=0.049, respectively) but CD34+CD45-VEGFR2+ cell frequency (median 2.2/million MNC versus 3.8/million MNC) and erythropoietin levels were not significantly different. Transient increases in EPC were observed in five infants with infection. Four preterm infants who developed bronchopulmonary dysplasia had undetectable or low EPC through the first 3 weeks of life.
CONCLUSIONS: Gestational age and postnatal age influenced circulating CD34+ and CD34+VEGFR2+ but not CD34+CD45-VEGFR2+ (EPC) cell frequencies. Circulating EPC in neonates may be influenced by clinical stress.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23312395      PMCID: PMC3633695          DOI: 10.1016/j.earlhumdev.2012.12.006

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN: 0378-3782            Impact factor:   2.079


  41 in total

1.  Bronchopulmonary dysplasia.

Authors:  A H Jobe; E Bancalari
Journal:  Am J Respir Crit Care Med       Date:  2001-06       Impact factor: 21.405

2.  Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood.

Authors:  David A Ingram; Laura E Mead; Hiromi Tanaka; Virginia Meade; Amy Fenoglio; Kelly Mortell; Karen Pollok; Michael J Ferkowicz; David Gilley; Mervin C Yoder
Journal:  Blood       Date:  2004-06-29       Impact factor: 22.113

3.  The effect of recombinant human erythropoietin on circulating hematopoietic progenitor cells in anemic premature infants.

Authors:  B Meister; H Maurer; B Simma; H Kern; H Ulmer; A Hittmair; F M Fink
Journal:  Stem Cells       Date:  1997       Impact factor: 6.277

Review 4.  Cord blood erythropoietin in relation to different markers of fetal hypoxia.

Authors:  R F Maier; K Böhme; J W Dudenhausen; M Obladen
Journal:  Obstet Gynecol       Date:  1993-04       Impact factor: 7.661

5.  Erythropoietin is a potent physiologic stimulus for endothelial progenitor cell mobilization.

Authors:  Christopher Heeschen; Alexandra Aicher; Ralf Lehmann; Stephan Fichtlscherer; Mariuca Vasa; Carmen Urbich; Christiane Mildner-Rihm; Hans Martin; Andreas M Zeiher; Stefanie Dimmeler
Journal:  Blood       Date:  2003-04-17       Impact factor: 22.113

6.  Human neonatal blood: stem cell content, kinetics of CD34+ cell decline and ex vivo expansion capacity.

Authors:  K Li; J Liu; T F Fok; F W Yau; A Wong; C K Li; M Yang; K W So; K W Chik; K S Tsang; M M Shing; P M Yuen
Journal:  Br J Haematol       Date:  1999-01       Impact factor: 6.998

7.  Serum erythropoietin levels in term and preterm infants during the first year of life.

Authors:  H Yamashita; J Kukita; S Ohga; H Nakayama; K Akazawa; K Ueda
Journal:  Am J Pediatr Hematol Oncol       Date:  1994-08

8.  Postnatal changes in erythropoietin levels in untransfused premature infants.

Authors:  M S Brown; R H Phibbs; J F Garcia; P R Dallman
Journal:  J Pediatr       Date:  1983-10       Impact factor: 4.406

9.  Decrease in incidence of bronchopulmonary dysplasia with erythropoietin administration in preterm infants: a retrospective study.

Authors:  Niti Rayjada; Lorayne Barton; Linda S Chan; Salvador Plasencia; Manoj Biniwale; Kim Chi Bui
Journal:  Neonatology       Date:  2012-08-24       Impact factor: 4.035

10.  Bone marrow-derived progenitor cells are important for lung repair after lipopolysaccharide-induced lung injury.

Authors:  Mitsuhiro Yamada; Hiroshi Kubo; Seiichi Kobayashi; Kota Ishizawa; Muneo Numasaki; Shinsaku Ueda; Takashi Suzuki; Hidetada Sasaki
Journal:  J Immunol       Date:  2004-01-15       Impact factor: 5.422

View more
  6 in total

1.  Mobilization of circulating progenitor cells following brain injury in premature neonates could be indicative of an endogenous repair process. A pilot study.

Authors:  N Efstathiou; V Soubasi; G Koliakos; G Kyriazis; D I Zafeiriou; A Slavakis; K Kantziou; T Pozotou; O Chatzizisi; V Drosou-Agakidou
Journal:  Hippokratia       Date:  2015 Apr-Jun       Impact factor: 0.471

2.  A Protective Effect of PPARα in Endothelial Progenitor Cells Through Regulating Metabolism.

Authors:  Yan Shao; Jianglei Chen; Li-Jie Dong; Xuemin He; Rui Cheng; Kelu Zhou; Juping Liu; Fangfang Qiu; Xiao-Rong Li; Jian-Xing Ma
Journal:  Diabetes       Date:  2019-08-26       Impact factor: 9.461

3.  Increased circulating endothelial progenitor cells (EPCs) in prepubertal children born prematurely: a possible link between prematurity and cardiovascular risk.

Authors:  Panagiota Markopoulou; Eleni Papanikolaou; Sofia Loukopoulou; Paraskevi Galina; Aimilia Mantzou; Tania Siahanidou
Journal:  Pediatr Res       Date:  2020-10-10       Impact factor: 3.756

4.  Endothelial Progenitor Cells as Prognostic Markers of Preterm Birth-Associated Complications.

Authors:  Mariane Bertagnolli; Anne Monique Nuyt; Bernard Thébaud; Thuy Mai Luu
Journal:  Stem Cells Transl Med       Date:  2016-07-27       Impact factor: 6.940

5.  Canonical Wnt Signaling Promotes Neovascularization Through Determination of Endothelial Progenitor Cell Fate via Metabolic Profile Regulation.

Authors:  Yan Shao; Jianglei Chen; Willard Freeman; Li-Jie Dong; Zhi-Hui Zhang; Manhong Xu; Fangfang Qiu; Yanhong Du; Juping Liu; Xiao-Rong Li; Jian-Xing Ma
Journal:  Stem Cells       Date:  2019-07-22       Impact factor: 6.277

6.  Endothelial progenitor cell number is not decreased in 34 children with Juvenile Dermatomyositis: a pilot study.

Authors:  Dong Xu; Akadia Kacha-Ochana; Gabrielle A Morgan; Chiang-Ching Huang; Lauren M Pachman
Journal:  Pediatr Rheumatol Online J       Date:  2017-05-17       Impact factor: 3.054

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.